Latest News

PDABs and upper-payment limits risk restricting medication access despite affordability intentions.

$100 billion 340B program lacks patient accountability; reform needed for charitable care obligations.

PDAB state implementation variations and how patients can engage in the process.

Q3 2023 Watch: HIV disparities coverage; debt ceiling crisis impacts; Medicaid disenrollment trends tracked.

Introduction to PDABs: structure, function, and importance for patient medication access.

340B reform must prioritize patients: charity care obligations and medical debt reduction.

Louisiana and Washington HCV subscription models save millions but fail elimination goals; cost alone isn't the barrier.

ADAP Fireside Chat addresses counterfeit medications, 340B reform, and public health workforce sustainability.

Q2 2022 Watch reviewing HCV treatment access across ADAPs, Medicaid, Veterans benefits, and assistance programs.

Pharmaceutical industry changes to 340B implementation impact pricing and accessibility for covered entities.

Biden's SOTU addresses harm reduction, endorses MAT Act; limited HIV-specific programming focus.

Q1 2022 assessment of HCV treatment access in ADAPs and Medicaid with DAA coverage and harm reduction data.

CANN reflects on 2021 advocacy spanning 340B drug pricing, HIV, hepatitis C, and substance use disorder policy.

Analyzes the role of contract pharmacies and intermediaries in 340B drug distribution and patient access.

Examines how 340B program expansion correlates with declining hospital charity care for vulnerable patients.

Explores accountability mechanisms in the 340B program and oversight requirements for patient protection.

Explains why transparency in 340B operations is critical for program integrity and patient access.

Introduces the 340B Drug Discount Program: its history, purpose, and significance for medication access.

Analyzes Biden health policy priorities including drug pricing reform and Medicare expansion.

Overview of the 340B Drug Discount Program for patient advocates covering program history and key policy issues.